Versartis

Company Profile

Versartis, Inc. is an endocrine-focused biopharmaceutical company initially developing VRS-317, a novel, long-acting form of recombinant human growth hormone, for the treatment of growth hormone deficiency (GHD).

Company Info

  • HQ: San Francisco, USA
Founders and CEO:
  • Jeff Cleland
Index Team:
Website:
versartis.com
Sector:
Healthcare
Status:
Current